-
Provision of medical psilocybin for the purpose of an observational study and the delivery of treatment through psilocybin‑assisted therapy in accordance with applicable laws and regulations, including recommended treatment guidelines in the Czech Republi
OTHER (SPNP04062026)06/2026 – 12/2026More Info -
Coverage of costs associated with processing clinical documentation for the planned study: HyPSI – Hyperscanning Psilocybin: Inter-brain synchrony during shared psilocybin administration and its association with social cognition
OTHER (SPNP03022026)03/2026 – 12/2026More Info -
INTEGRATE - Interdisciplinary Network for Training, Education, and Growing Research into Applications of and Therapeutic Expertise around Psychedelics
EC (101226862)03/2026 – 02/2030More Info -
Implementation of activities and research focused on the antidepressant potential of the psychedelics psilocybin and ketamine, and on the neurobiology of the antidepressant effect
OTHER01/2026 – 12/2026More Info -
Cost Action: Psychedelic renaissance: turn on, tune in and drop in(PSY-NET)
EC (CA24130)11/2025 – 10/2029More Info -
From Magic to Pharmaceutical Drugs Using Psychoactive Mushrooms
MŠMT (LUAIZ24146)08/2024 – 07/2027More Info -
PsyPal: Psilocybin Therapy for Psychological Distress in Palliative Care Patients
10113737801/2024 – 12/2027More Info -
Brain dynamics, OP JAK
MŠMT (CZ.02.01.01/00/22_008/0004643)01/2024 – 06/2028More Info -
NPS-FORTOX, New psychoactive substances: forensic-toxicology research center
MV (VK01010212)01/2023 – 12/2026More Info -
Research of potencial impact of Psilocybin and ketamine in treatment of depression
Ostatní (SPNP20230712)04/2022 – 12/2026More Info